UniProt ID | CACB1_HUMAN | |
---|---|---|
UniProt AC | Q02641 | |
Protein Name | Voltage-dependent L-type calcium channel subunit beta-1 | |
Gene Name | CACNB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 598 | |
Subcellular Localization |
Cell membrane, sarcolemma Peripheral membrane protein Cytoplasmic side. |
|
Protein Description | The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting.. | |
Protein Sequence | MVQKTSMSRGPYPPSQEIPMEVFDPSPQGKYSKRKGRFKRSDGSTSSDTTSNSFVRQGSAESYTSRPSDSDVSLEEDREALRKEAERQALAQLEKAKTKPVAFAVRTNVGYNPSPGDEVPVQGVAITFEPKDFLHIKEKYNNDWWIGRLVKEGCEVGFIPSPVKLDSLRLLQEQKLRQNRLGSSKSGDNSSSSLGDVVTGTRRPTPPASAKQKQKSTEHVPPYDVVPSMRPIILVGPSLKGYEVTDMMQKALFDFLKHRFDGRISITRVTADISLAKRSVLNNPSKHIIIERSNTRSSLAEVQSEIERIFELARTLQLVALDADTINHPAQLSKTSLAPIIVYIKITSPKVLQRLIKSRGKSQSKHLNVQIAASEKLAQCPPEMFDIILDENQLEDACEHLAEYLEAYWKATHPPSSTPPNPLLNRTMATAALAASPAPVSNLQGPYLASGDQPLERATGEHASMHEYPGELGQPPGLYPSSHPPGRAGTLRALSRQDTFDADTPGSRNSAYTELGDSCVDMETDPSEGPGLGDPAGGGTPPARQGSWEDEEEDYEEELTDNRNRGRNKARYCAEGGGPVLGRNKNELEGWGRGVYIR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MVQKTSMSRGPYPPS CCCCCCCCCCCCCCC | 33.58 | 24719451 | |
26 | Phosphorylation | PMEVFDPSPQGKYSK CCCCCCCCCCCCCCC | 31.53 | 24719451 | |
31 | Phosphorylation | DPSPQGKYSKRKGRF CCCCCCCCCCCCCCC | 26.67 | 24719451 | |
32 | Phosphorylation | PSPQGKYSKRKGRFK CCCCCCCCCCCCCCC | 29.48 | 24719451 | |
44 | Phosphorylation | RFKRSDGSTSSDTTS CCCCCCCCCCCCCCC | 30.06 | 24719451 | |
45 | Phosphorylation | FKRSDGSTSSDTTSN CCCCCCCCCCCCCCC | 37.47 | 30576142 | |
46 | Phosphorylation | KRSDGSTSSDTTSNS CCCCCCCCCCCCCCC | 28.10 | 30576142 | |
47 | Phosphorylation | RSDGSTSSDTTSNSF CCCCCCCCCCCCCCC | 38.78 | 24076635 | |
50 | Phosphorylation | GSTSSDTTSNSFVRQ CCCCCCCCCCCCCCC | 30.79 | 24076635 | |
51 | Phosphorylation | STSSDTTSNSFVRQG CCCCCCCCCCCCCCC | 32.35 | 22210691 | |
53 | Phosphorylation | SSDTTSNSFVRQGSA CCCCCCCCCCCCCCC | 25.53 | 22210691 | |
59 | Phosphorylation | NSFVRQGSAESYTSR CCCCCCCCCCCCCCC | 22.11 | 23312004 | |
62 | Phosphorylation | VRQGSAESYTSRPSD CCCCCCCCCCCCCCC | 33.17 | 27251275 | |
63 | Phosphorylation | RQGSAESYTSRPSDS CCCCCCCCCCCCCCC | 10.55 | 25884760 | |
64 | Phosphorylation | QGSAESYTSRPSDSD CCCCCCCCCCCCCCC | 27.78 | 27251275 | |
65 | Phosphorylation | GSAESYTSRPSDSDV CCCCCCCCCCCCCCC | 33.68 | 27251275 | |
68 | Phosphorylation | ESYTSRPSDSDVSLE CCCCCCCCCCCCCHH | 48.95 | 27251275 | |
70 | Phosphorylation | YTSRPSDSDVSLEED CCCCCCCCCCCHHHH | 44.22 | 27251275 | |
73 | Phosphorylation | RPSDSDVSLEEDREA CCCCCCCCHHHHHHH | 34.75 | 23312004 | |
175 | Ubiquitination | LRLLQEQKLRQNRLG HHHHHHHHHHHCCCC | 44.90 | 29967540 | |
183 | Phosphorylation | LRQNRLGSSKSGDNS HHHCCCCCCCCCCCC | 38.90 | 22673903 | |
184 | Phosphorylation | RQNRLGSSKSGDNSS HHCCCCCCCCCCCCC | 29.10 | 22673903 | |
186 | Phosphorylation | NRLGSSKSGDNSSSS CCCCCCCCCCCCCCC | 54.01 | 26437602 | |
190 | Phosphorylation | SSKSGDNSSSSLGDV CCCCCCCCCCCCCCC | 36.02 | 26437602 | |
192 | Phosphorylation | KSGDNSSSSLGDVVT CCCCCCCCCCCCCCC | 29.42 | 19764811 | |
193 | Phosphorylation | SGDNSSSSLGDVVTG CCCCCCCCCCCCCCC | 38.02 | 19764811 | |
205 (in isoform 2) | Phosphorylation | - | 39.84 | 22673903 | |
209 (in isoform 2) | Phosphorylation | - | 41.60 | 22673903 | |
214 (in isoform 2) | Phosphorylation | - | 42.30 | 22673903 | |
241 (in isoform 2) | Phosphorylation | - | 29.18 | 26437602 | |
242 | Phosphorylation | VGPSLKGYEVTDMMQ ECCCCCCCCHHHHHH | 12.97 | 24275569 | |
242 (in isoform 2) | Phosphorylation | - | 12.97 | 28348404 | |
244 (in isoform 2) | Phosphorylation | - | 4.07 | 26437602 | |
245 | Phosphorylation | SLKGYEVTDMMQKAL CCCCCCHHHHHHHHH | 13.26 | 24275569 | |
247 (in isoform 2) | Phosphorylation | - | 1.93 | 26437602 | |
248 (in isoform 2) | Phosphorylation | - | 4.04 | 27732954 | |
261 (in isoform 2) | Ubiquitination | - | 45.47 | 21906983 | |
265 | Phosphorylation | HRFDGRISITRVTAD HHCCCCCEEEEEECC | 19.29 | 24719451 | |
267 | Phosphorylation | FDGRISITRVTADIS CCCCCEEEEEECCHH | 16.58 | 23312004 | |
270 | Phosphorylation | RISITRVTADISLAK CCEEEEEECCHHHHH | 18.47 | 23312004 | |
274 | Phosphorylation | TRVTADISLAKRSVL EEEECCHHHHHHHHH | 23.87 | 29083192 | |
335 | Phosphorylation | HPAQLSKTSLAPIIV CHHHCCCCCCCCEEE | 26.12 | 22210691 | |
336 | Phosphorylation | PAQLSKTSLAPIIVY HHHCCCCCCCCEEEE | 26.69 | 22210691 | |
343 | Phosphorylation | SLAPIIVYIKITSPK CCCCEEEEEEECCHH | 6.01 | 22210691 | |
412 | Phosphorylation | LEAYWKATHPPSSTP HHHHHHHHCCCCCCC | 31.05 | 23312004 | |
416 | Phosphorylation | WKATHPPSSTPPNPL HHHHCCCCCCCCCCC | 51.82 | 20886841 | |
417 | Phosphorylation | KATHPPSSTPPNPLL HHHCCCCCCCCCCCC | 51.19 | 28348404 | |
418 | Phosphorylation | ATHPPSSTPPNPLLN HHCCCCCCCCCCCCC | 47.29 | 23312004 | |
430 (in isoform 3) | Phosphorylation | - | 11.14 | 22210691 | |
441 (in isoform 3) | Phosphorylation | - | 30.66 | 22210691 | |
447 | Phosphorylation | VSNLQGPYLASGDQP HHHCCCCCCCCCCCC | 23.02 | 25884760 | |
449 (in isoform 3) | Phosphorylation | - | 12.96 | 22210691 | |
450 (in isoform 3) | Phosphorylation | - | 40.06 | 22210691 | |
462 | Phosphorylation | LERATGEHASMHEYP CHHHCCCCCCHHCCC | 25.17 | 32142685 | |
468 (in isoform 3) | Phosphorylation | - | 11.23 | 26437602 | |
475 (in isoform 2) | Phosphorylation | - | 24.11 | 22210691 | |
486 (in isoform 2) | Phosphorylation | - | 36.20 | 22210691 | |
494 (in isoform 2) | Phosphorylation | - | 3.33 | 22210691 | |
495 | Phosphorylation | AGTLRALSRQDTFDA HHHHHHHHCCCCCCC | 27.23 | - | |
495 (in isoform 2) | Phosphorylation | - | 27.23 | 22210691 | |
499 | Phosphorylation | RALSRQDTFDADTPG HHHHCCCCCCCCCCC | 18.31 | 30624053 | |
513 (in isoform 2) | Phosphorylation | - | 25.17 | 26437602 | |
540 | Phosphorylation | GDPAGGGTPPARQGS CCCCCCCCCCCCCCC | 29.40 | 24076635 | |
547 | Phosphorylation | TPPARQGSWEDEEED CCCCCCCCCCCCHHH | 20.96 | 24719451 | |
593 | Methylation | NELEGWGRGVYIR-- CCCCCCCCCEECC-- | 25.54 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CACB1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CACB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CACB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NED4L_HUMAN | NEDD4L | physical | 19953087 | |
A4_HUMAN | APP | physical | 21832049 | |
CACB2_HUMAN | CACNB2 | physical | 28514442 | |
CACB3_HUMAN | CACNB3 | physical | 28514442 | |
CBARP_HUMAN | C19orf26 | physical | 28514442 | |
WDR75_HUMAN | WDR75 | physical | 28514442 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB04855 | Dronedarone |
DB00898 | Ethanol |
DB00308 | Ibutilide |
DB00653 | Magnesium Sulfate |
DB00393 | Nimodipine |
DB00421 | Spironolactone |
DB00661 | Verapamil |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-418, AND MASSSPECTROMETRY. |